1. Assessing user fees under the Prescription Drug User Fee Amendments of 2017 Publication: Silver Spring, MD : Center for Drug Evaluation and Research, May 2018 Subject(s): Fees and ChargesInvestigational New Drug Application -- economicsPrescription Drugs -- economicsBiological Products -- economicsOrphan Drug Production -- economicsHumansUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
2. Assessing user fees under the biosimilar user fee amendments of 2017 Publication: Silver Spring, MD : Center for Drug Evaluation and Research, June 2018 Subject(s): Biosimilar Pharmaceuticals -- economicsFees and ChargesInvestigational New Drug Application -- economicsDrug Evaluation -- economicsParenteral Nutrition Solutions -- economicsHumansUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
3. Relative value units (RVUs): the basics Publication: Washington, D.C. : George Washington University, [2009] Subject(s): Medicare -- economicsRelative Value ScalesFees and ChargesPractice Patterns, Physicians'HumansUnited StatesCenters for Medicare & Medicaid Services (U.S.)
4. Air ambulance: data collection and transparency needed to enhance DOT oversight : report to the Committee on Transportation and Infrastructure, House of Representatives Publication: Washington, D.C. : U.S. Government Accountability Office, July 2017 Subject(s): Air Ambulances -- economicsFees and ChargesInsurance Coverage -- economicsCost SharingData CollectionDisclosureGovernment RegulationHumansUnited StatesUnited States. Department of Transportation.Centers for Medicare & Medicaid Services (U.S.)